For many women, the dream of starting a family is one of life’s most cherished goals. But what happens when a test reveals low AMH (Anti-Müllerian Hormone) levels, a marker for diminished ovarian reserve? While this diagnosis can feel overwhelming, it’s important to remember that low AMH doesn’t mean the door to parenthood is closed.
Dr. Nikhil Chitnis, a leading fertility specialist, offers a fresh perspective. “Low AMH is just one piece of the puzzle,” he explains. “With advancements in reproductive medicine, we can tailor solutions to maximize every opportunity.” At the Dr. Maltibai Chitnis IVF Hospital, a leading IVF centre in Thane, patients are guided through a range of cutting-edge options to tackle this challenge head-on. Under Dr. Chitnis’s leadership, the hospital has embraced innovation and technology, consistently elevating its fertility care standards.
You May Also Like This
Low AMH often sparks concerns about the ability to conceive naturally as many women equate it with a ticking biological clock, fearing that their chances of conception are slipping away. But as Dr. Chitnis emphasizes, fertility is not solely about the number of eggs. “What matters most is the quality of the eggs and embryos,” he says. Advanced technologies like Intracytoplasmic Sperm Injection (ICSI) and preimplantation genetic testing (PGT) have shifted the focus from quantity to precision, ensuring that every viable egg has the best chance of success.
One of the most significant breakthroughs for women with low AMH is ICSI, where a single, healthy sperm is injected directly into an egg. This targeted approach minimizes wastage and maximizes fertilization success. Cryopreservation, or freezing eggs and embryos, is another critical tool. This allows women to preserve their fertility for future use, particularly if they’re not ready to conceive immediately. “Egg freezing offers flexibility,” says Dr. Chitnis. “It’s especially beneficial for younger women diagnosed with low AMH who want to delay childbearing.”
Time plays a vital role in fertility care, especially for women with low AMH. Seeking help early ensures access to a broader range of options. Dr. Chitnis advises women to consult a specialist as soon as they notice challenges conceiving. “Low AMH isn’t something you should wait on,” he cautions. “The earlier we begin, the better the outcomes.” Another key strategy is monitoring hormonal health alongside ovarian reserve. Treatments such as ovarian stimulation protocols can help retrieve more eggs during an IVF cycle. “We customize stimulation plans to get the most out of each cycle,” says Dr. Chitnis. “Even a small improvement in egg retrieval can make a big difference.”
At Dr. Malatibai Chitnis Hospital, fertility treatment plans are designed to align with each patient’s unique needs. For women with low AMH, combining techniques like ICSI with tailored hormonal support often yields positive results. Additionally, Frozen Embryo Transfer (FET) offers an effective option by transferring previously frozen embryos in optimal conditions, bypassing the need for repeated stimulations.
Advanced technologies play a critical role in addressing low AMH at Dr. Malatibai Chitnis Hospital. Tools like AI-assisted embryo selection and non-invasive genetic testing allow for greater precision, ensuring that only the healthiest embryos are selected for implantation. Cryopreservation provides patients with the option to freeze and store embryos for future use, creating flexibility in treatment planning. These innovations ensure that every step of the process is optimized for success. “When you’re dealing with a limited number of eggs, precision is key. Our technologies help us identify the healthiest embryos and provide the best possible conditions for implantation,” Dr. Chitnis explains.
Globally, several emerging treatments are shaping the future of fertility care for women with low AMH. Platelet-Rich Plasma (PRP) therapy, for instance, is being explored for its potential to rejuvenate ovarian function. Similarly, stem cell therapy is showing promise in regenerating ovarian tissue and increasing egg production. Mitochondrial Replacement Therapy (MRT), designed to replace defective mitochondria in eggs with healthy ones from a donor, aims to improve egg quality in age-related fertility challenges. Even supplementation therapies like DHEA and CoQ10 are gaining attention for their role in supporting hormonal balance and mitochondrial function.
“While many of these treatments are still in the experimental phase, they highlight the exciting possibilities ahead,” says Dr. Chitnis. “We stay informed about global advancements because they set the stage for the next wave of breakthroughs. As these technologies become clinically validated, they will undoubtedly open new doors for patients worldwide.”
For women who struggle despite these measures, egg donation remains a viable and often successful solution. “While it may not be the first choice for many, using donor eggs provides excellent outcomes for women with severely diminished ovarian reserve,” Dr. Chitnis explains. “The goal is to create the best possible path to parenthood, whatever form that takes.”
Dr. Chitnis believes in equipping patients with information so they can make confident, informed decisions. “Fertility is not a one-size-fits-all journey,” he says. “Understanding your options—whether it’s ICSI, PGT, or egg donation—can turn what seems like a limitation into an opportunity.”
A diagnosis of low AMH can feel like a setback, but it’s far from a dead end. With advancements in reproductive medicine, coupled with a compassionate, personalized approach, women have more opportunities than ever to achieve their dreams of parenthood. “Low AMH doesn’t define your journey,” says Dr. Chitnis. “It’s just a starting point. Together, we can find a solution that works.”
For women facing low AMH, this evolving landscape of fertility care offers not just solutions but also hope. By focusing on advanced techniques and a patient-centered approach, Dr. Malatibai Chitnis Hospital continues to set the standard for fertility treatment under the visionary leadership of Dr. Nikhil Chitnis.
Start your journey to parenthood today. Contact Dr. Malatibai Chitnis Hospital for a consultation:
Contact Dr. Nikhil Chitnis
Phone: +91 7900390095
Dr. Malatibai Chitnis Hospital,
Near, Govind Bachaji Rd,
Chitnis Chowk, Talav Pali,
Malatibai, Thane West,
Maharashtra 400602
About Dr. Nikhil Chitnis
Dr Nikhil Chitnis heads the Dr. Malatibai Chitnis Hospital, a legacy hospital synonymous with being dedicated to offering the latest gynecological treatments that ensure women’s holistic health for motherhood and beyond. Dr. Nikhil Chitnis and his team go beyond treating the physical health of the patient. They go further by addressing the mental and emotional well-being of the patient by offering support for concerns such as postpartum depression, sexual dysfunction, and menopausal symptoms. It offers a comprehensive array of assisted reproductive technologies (ART) to assist women facing fertility issues, encompassing IVF, IUI, and hormone therapies.
